T-Cell Therapy Market Growth 2022-2028: Rising Awareness Regarding Advanced Cancer Treatments

The global T-cell therapy market size is expected to reach USD 21 Billion in 2028 and register a CAGR of 20.4% over the forecast period, according to the latest report by Reports and Data.

The global T-cell therapy market size is expected to reach USD 21 Billion in 2028 and register a CAGR of 20.4% over the forecast period, according to the latest report by Reports and Data. Key factors such as increasing geriatric population globally, rising awareness about advanced cancer treatments, and major prevalence of cancers are driving market revenue growth. T-cell therapy is a type of immunotherapy that involves genetic modification of T-cells. This process is used to treat different types of cancers.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/2508

There are mainly three main types of T-cell therapies; CAR T-cell therapy, T-cell receptor (TCR)-based, and tumor infiltrating lymphocytes (TIL)-based. CAR T-cell therapy or Chimeric Antigen Receptor T-cell therapy is one of the most effective methods of cancer treatment. CAR T-cell therapy segment accounted for majority revenue share in the global market in 2020. This can be attributed to increasing number of clinical trials for CAR T-cell therapy and increasing investment in research related to CAR T-cell therapy.

North America accounted for second-largest revenue share in the global market in 2020. Major revenue contributors to revenue of the North America market are the United States and Canada, respectively. Factors such as growing number of clinical trials of T-cell therapies being conducted are driving revenue growth of the market in this region.

Asia Pacific market accounted for a 23.2% revenue share in the global market in 2020 and is expected to register fastest CAGR than other regional markets over the forecast period. This can be attributed to growing focus on cancer research, and ongoing development of healthcare sector.

Europe accounted for a significant revenue share in 2020 and the trend is expected to continue over the forecast period. Increasing application of T-cell therapy in different cancer treatments is one of the key factors driving revenue growth of the market in this region.

Some Key Highlights from the Report:

    • In January 2021, OrganaBio launched a new cell product, ImmunoPAC-T-CB T cells. These cells are obtained from full-term umbilical cord blood taken from donors that supports allogeneic immune cell-based therapy development.
    • Research segment accounted for largest revenue share in the global market in 2020. This can be attributed to rising focus on research of T-cell therapy, and increasing investment in cell therapy-based clinical research and development activities.

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.

Top Companies Profiled in the Report:

Novartis AG, Merck KGaA, Gilead Sciences Inc., TCR2 Therapeutics Inc., Bluebird Bio Inc., Sorrento Therapeutics, Fate Therapeutics, Pfizer Inc., Amgen, and Celgene Corporation.

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/t-cell-therapy-market

T-Cell Therapy Market Segmentation:

Modality Outlook (Revenue, USD Billion; 2018-2028)

  • Research
  • Commercialized

Therapy Outlook (Revenue, USD Billion; 2018-2028)

  • CAR T-cell therapy
  • T-cell receptor (TCR)-based
  • Tumor infiltrating lymphocytes (TIL)-based

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/2508

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore Latest Trending Research Reports By Reports and Data’s:

Alzheimers Pipeline Drug Market By Type (Namenda, Ebixa, Axura, Aricept, Nootropil, Exelon, Memary, Solanezumab, And LuAe58054), Application Type (Hospital, Drug Store), And Region- Global Forecast To 2027

Disposable Surgical Gloves Market By Type (Surgical And Examination), Application Type (Latex and Synthetic), By End User (Hospitals And Clinics, Diagnostics and Pathology Labs, Others) And Region - Global Forecast To 2027

Diabetes Market By Disease Type, By Treatment Type, By Devices, By End-user And Segment Forecasts, 2019-2027

Ankylosing Spondylitis (AS) Market Size, Share And Industry Analysis By Treatment Type (Medication, Surgery, Therapy, Others), By Care Providing Organization (Hospital, Care Home, Clinic, Others), By Application (Adults, Juveniles) And Region, Segment Forecasts To 2027

Powered Air Purifying Respirator (PAPR) Market Size, Share And Industry Analysis By Product (Half Mask, Full Face Mask, Helmets, hoods, and visors), By Target Population (Children, Adults (Below 60), Pregnant Women, Elderly (Above 60)) And Region, Segment Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs